Adalimumab, sold under the brand name Humira among others, is a medication used to treat rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, Crohn's disease, ulcerative colitis, psoriasis, hidradenitis suppurativa, uveitis, and juvenile idiopathic arthritis.

Adalimumab-Associated Hemorrhagic Pericarditis

Vyas, Rohit MD1; Adeel, Firas A. MD1; Sheikh, Taha MD1; Syed, Mubbasher MD1,2; Altorok, Nezam MD1,3

American Journal of Therapeutics: June 21, 2019 - Volume Publish Ahead of Print - Issue - p

doi: 10.1097/MJT.0000000000001019

Letters to the Editor: PDF Only

BUY

PAP

• Author Information
• Article Metrics

Copyright © 2019 Wolters Kluwer Health, Inc. All rights reserved.